Application of ultrasound guided percutaneous transhepatic cholangial drainage in the treatment of malignant obstructive jaundice
-
摘要:
目的探讨超声引导下经皮经肝胆管置管引流术(PTCD)对恶性梗阻性黄疸患者的治疗效果。 方法回顾分析我院2013年4月~2015年9月期间,超声引导下PTCD治疗的97例恶性梗阻性黄疸患者临床资料,观察分析治疗后并发症及其预后,同时比较治疗前后下述指标的变化:总胆红素、直接胆红素、胆汁酸、谷草转氨酶、谷丙氨酶、谷氨酰转肽酶、碱性磷酸酶、白蛋白、前白蛋白。 结果97例患者均置管成功,成功率100%,PTCD术后患者恶心、呕吐、腹胀、皮肤瘙痒等症状明显改善,黄疸减轻。97例患者,术后出现2例胆道感染,发生率2.06%;1例急性胰腺炎,发生率1.03%;上述并发症经保守治疗后,2周内痊愈。PTCD治疗后总胆红素、直接胆红素、胆汁酸、谷草转氨酶、谷丙氨酶、谷氨酰转肽酶、碱性磷酸酶水平均显著下降,白蛋白、前白蛋白水平显著提高,均有统计学意义(P<0.05)。 结论恶性梗阻性黄疸患者通过超声引导下实施PTCD治疗,不仅能够快速降低血清胆红素水平、促进黄疸消退、改善肝功能,而且具有实时准确、安全可靠等特点,疗效显著,应予推广。 -
关键词:
- 超声 /
- 经皮经肝穿刺胆管置管引流术 /
- 肿瘤 /
- 梗阻性黄疸
Abstract:Objective To explore the therapeutic effect of ultrasound guided percutaneous biliary drainage in patients with malignant obstructive jaundice. Methods A total of 97 cases with malignant obstruction jaundice underwent percutaneous transhepatic cholangioma drainge (PTCD) using the guidance of ultrasound in our hospital since April 2013 to September 2015. All clinical data before PTCD were retrospectively compared with those after PTCD, including TBIL, DBIL, TBA, AST, ALT, GGT, ALP, ALB and PA. Postoperative complications and prognosis were also observed. Results All cases were performed PTCD using the guidance of ultrasound successfully. Nausea, vomiting, abdominal distension, loss of appetite, skin itching and jaundice significantly improved. In 97 cases, there were two cases of biliary tract infection(the incidence rate of 2.06%)and one case of acute pancreatitis(the incidence rate of 1.03%), which were cured with medicine. The levels of all the laboratory index including TBIL, DBIL, TBA, AST, ALT, GGT, ALP, ALB and PA after treatment were significantly improved in comparison with those levels before treatment (P<0.05). Conclusions PTCD using ultrasound guidance in patients with malignant obstructive jaundice can not only reduce the serum bilirubin level and improve liver function, but also has merits of accuracy, safety and reliability. -
表 1 PTCD治疗前后TBIL、DBIL、TBA水平对比(μ/L, x±s, n=97)
组别 TBIL DBIL TBA 治疗前 241.53±23.57 170.41±25.24 113.89±12.15 治疗后 57.11±6.36 34.62±5.17 6.85±1.13 t 74.399 51.909 86.394 P <0.01 <0.01 <0.01 表 2 PTCD治疗前后AST、ALT、GGT、ALP水平对比(μ/L, x±s, n=97)
组别 AST ALT GGT ALP 治疗前 111.53±12.15 134.59±21.72 593.64±32.76 505.38±51.85 治疗后 48.71±6.34 30.22±5.59 162.17±11.75 175.53±29.51 t 45.146 45.833 122.099 54.453 P <0.01 <0.01 <0.01 <0.01 表 3 PTCD治疗前后ALB、PA水平对比(x±s, n=97)
组别 ALB(g/L) PA(mg/L) 治疗前 31.57±0.45 168.53±2.71 治疗后 35.22±0.58 180.56±3.52 t 48.969 26.671 P <0.01 <0.01 -
[1] 金壮, 曹军英, 张筠, 等. 超声引导下PTCD与ERCP联合治疗恶性 梗阻性黄疸十例[J]. 介入放射学杂志, 2015, 15(3): 223-5. [2] 汤波, 张志峰, 杨芳. 超声引导下PTCD在恶性梗阻性黄疸治疗中的 临床价值分析[J]. 医学影像学杂志, 2015, 25(11): 2056-8. [3] 游淑红, 洪涛, 陶荣, 等. 彩色多普勒超声引导下经皮经肝胆管穿刺 置管引流术40例分析体会[J]. 东南国防医药, 2015, 20(6): 619-21. [4] 周亚龙, 程千里, 林云志, 等. PTCD 治疗合并感染性休克的急性梗阻 性化脓性胆管炎的疗效及安全性分析[J]. 湖南师范大学学报:医学 版, 2015, 15(3): 140-2. [5] 陈秋恋, 吴珊珊, 刘朝辉. 恶性梗阻性黄疸合并急性胆管炎患者术前 胆道引流的效果观察[J]. 临床肝胆病杂志, 2015, 31(10): 1652-5. [6] 周磊, 刘会春, 李宗狂, 等. 经皮胆道金属支架置入姑息性治疗肝门部 胆管癌[J]. 中国微创外科杂志, 2015, 22(11): 998-1000, 1014. [7] 张红军, 常树勋, 王晓鹏, 等. 经皮肝穿刺胆道引流术联合支架植入术 对恶性梗阻性黄疸的疗效分析[J]. 实用医学影像杂志, 2015, 16(6): 476-8. [8] 付梅, 张兆娜. 恶性梗阻性黄疸患者行PTCD和PTBS前后生活质量 调查分析[J]. 泰山医学院学报, 2015, 36(10): 1143-5. [9] 滕春雨. 恶性梗阻性黄疸患者经皮穿刺肝胆管引流术后胆管感染的 临床分析及预防研究[J]. 医学综述, 2015, 25(11): 2107-9. [10] 吴武军, 杜立学, 杨俊武, 等. 经皮经肝胆管引流在肝内梗阻性重症胆 管炎损伤控制中的临床价值[J]. 中华肝胆外科杂志, 2014, 20(2): 101-4. [11] 刘宇亭, 金震东, 李兆申, 等. 内镜超声引导下胆管引流的研究进展 [J]. 中华消化内镜杂志, 2015, 18(4): 270-2. [12] 范恒伟, 刘会春, 李宗狂, 等. 经PTCD途径胆道金属支架置入术治疗 恶性梗阻性黄疸137 例临床疗效分析[J]. 肝胆外科杂志, 2013, 21 (2): 94-7.
计量
- 文章访问数: 446
- HTML全文浏览量: 223
- PDF下载量: 0
- 被引次数: 0